期刊文献+

海藻酸钠的疏水改性及其对药物的缓释 被引量:15

Preparation and drug-controlled release of hydrophobically modified alginate
下载PDF
导出
摘要 为了提高对疏水性药物的负载量和缓释作用,将海藻酸钠与辛胺进行不同程度的疏水改性。对改性后的聚合物结构进行FTIR、1H NMR表征;并将聚合物分散于3%的CaCl2溶液中制备成凝胶微球,对小分子疏水性药物布洛芬进行了包埋释放实验。结果表明,辛胺侧链成功接枝于海藻酸钠的羧基上,接枝率与辛胺用量成正比,由其制备的凝胶微球对布洛芬包封率提高,且具有较好的药物缓释作用。 In order to increase the loading dose of hydrophobic drugs on alginate and control the drug release rate, sodium alginate was hydrophobically modified with n-octylamine through the reaction of carbodiimide. The modified alginate was characterized with FTIR and 1H NMR. The modified alginate was made into microsphere beads in aqueous solution of 3wt% calcium chloride. A hydrophobic drug of ibuprofen was loaded on the modified alginate for the in vitro investigation on the drug-controlled release. The results indicated that the drug-loaded dose was obviously increased and the release rate could be well controlled.
出处 《功能材料》 EI CAS CSCD 北大核心 2010年第9期1568-1570,1574,共4页 Journal of Functional Materials
基金 973国际合作资助项目(中荷战略联盟项目)(2004CB720604)
关键词 海藻酸钠 辛胺 疏水改性 缓释 alginate n-octylamine hydrophobical controlled-release
  • 相关文献

参考文献8

  • 1Bodmeier R, Chen H. [J]. Journal of Controlled Release, 1989, 10:167-175.
  • 2Dubernet, Dubernet C, Benoit J P, et al. [J]. Journal of Microencapsulation, 1990, 7 : 555-565.
  • 3Donati I, Gamini A, SkjkaBrk G, et al. [J]. Carbohydrate Research, 2003, 338: 1139-1142.
  • 4Haug A, Larsen B, Smidsrφd O. [J]. Acta Chemica Scandinavica, 1967, 21: 691-704.
  • 5Remminghorst U, Rehm B H.[J]. Bioteehnology Letters, 2006, 28: 1701-1712.
  • 6Liang H F, Hong M H, Ho R M, et al. [J]. Biomacromolecules, 2004, 5(5) :1917-1925.
  • 7Gombotz W R, Wee S F.[J]. Advanced Drug Delivery Reviews, 1998, 31:267-285.
  • 8Nakajima N, Ikada Y. [J]. Bioconjugate Chem, 1995, 6 (1) : 123-130.

同被引文献195

引证文献15

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部